KMI vs VOR · P/E 24, rev $16.94B vs $813.9M cap
Kinder Morgan Inc (KMI) versus Vor Biopharma Inc (VOR) — a side-by-side from cached financials, not a winner call.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Vor Biopharma Inc (VOR) is a biotechnology company listed on NASDAQ.
Latest reported KMI revenue for 2025-12-31 was $16.94B. Net income was $3.06B. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
VOR does not have a complete income-statement cache yet.
KMI currently screens at market cap $62.53B and trailing P/E 24.2. VOR currently screens at market cap $813.9M.
Not investment advice. Open the KMI and VOR stock pages for the full models.
Not investment advice.